
How FDA Inspects mRNA and Advanced Therapy Manufacturing Facilities
Navigating federal oversight for next-generation platforms requires a profound structural realignment of quality frameworks. This comprehensive technical guide analyzes what investigators target during an mRNA manufacturing FDA inspection. Discover how to effectively manage lipid nanoparticle formulation validation, enzymatic transcription data lineage, and single-use operational integrity.










